ArticleOncotarget2016

Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.

Ameet K Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.